Astria Therapeutics, Inc.
ATXSDelisted Jan 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Astria Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- 0 vs. Q4 2021
- Shares held
- 6.21M
- +116.9K (+1.9%) vs. Q4 2021
- Total value
- $41.7M
- +$8.83M (+26.9%) vs. Q4 2021
- New holders
- 6
- 7 more added
- Sold out
- 6
- 8 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATXS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 141 | $738.2M |
| Q3 2025 | 115 | $409.0M |
| Q2 2025 | 106 | $309.9M |
| Q1 2025 | 116 | $311.4M |
| Q4 2024 | 111 | $523.4M |
| Q3 2024 | 103 | $622.1M |
| Q2 2024 | 100 | $505.8M |
| Q1 2024 | 102 | $810.6M |
| Q4 2023 | 80 | $282.6M |
| Q3 2023 | 68 | $171.4M |
| Q2 2023 | 76 | $205.5M |
| Q1 2023 | 66 | $311.6M |
| Q4 2022 | 61 | $326.1M |
| Q3 2022 | 43 | $88.8M |
| Q2 2022 | 30 | $17.2M |
| Q1 2022 | 33 | $41.7M |
| Q4 2021 | 33 | $32.8M |
| Q3 2021 | 36 | $65.2M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Astria Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 15 | $0 | 0.00% | −3,892−99.6% | Reduced |
| Wells Fargo & Company | 58 | $0 | 0.00% | 00.0% | Unchanged |
| Key Financial Inc | 66 | $0 | 0.00% | 00.0% | Unchanged |
| SOA Wealth Advisors, LLC. | 7 | $0 | 0.00% | +7 | New |
| Royal Bank of Canada | 145 | $1.00K | 0.00% | +80+123.1% | Added |
| Benjamin F. Edwards & Company, Inc. | 333 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 407 | $3.00K | 0.00% | −1,551−79.2% | Reduced |
| Simplex Trading, LLC | 1,335 | $8.00K | 0.00% | +1,335 | New |
| Morgan Stanley | 3,008 | $20.0K | 0.00% | −56−1.8% | Reduced |
| Group One Trading, L.P. | 11,431 | $77.0K | 0.00% | +9,131+397.0% | Added |
| Schonfeld Strategic Advisors LLC | 11,500 | $77.0K | 0.00% | +11,500 | New |
| Corton Capital Inc. | 11,597 | $78.0K | 0.03% | +11,597 | New |
| Occudo Quantitative Strategies LP | 15,341 | $103.0K | 0.01% | −116−0.8% | Reduced |
| Susquehanna International Group, LLP | 18,530 | $124.0K | 0.00% | +18,530 | New |
| Northern Trust Corp | 20,099 | $135.0K | 0.00% | −1,914−8.7% | Reduced |
| Oppenheimer & Co Inc | 23,616 | $158.0K | 0.00% | +1,800+8.3% | Added |
| D. E. Shaw & Co., Inc. | 24,809 | $166.0K | 0.00% | −13,398−35.1% | Reduced |
| Samsara BioCapital, LLC | 25,000 | $168.0K | 0.04% | 00.0% | Unchanged |
| Botty Investors LLC | 25,747 | $173.0K | 0.06% | 00.0% | Unchanged |
| Artal Group S.A. | 33,333 | $224.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 50,386 | $338.0K | 0.00% | −2,687−5.1% | Reduced |
| Bridgeway Capital Management, LLC | 64,279 | $431.0K | 0.01% | +19,279+42.8% | Added |
| Geode Capital Management, LLC | 78,107 | $524.0K | 0.00% | +13,093+20.1% | Added |
| Ikarian Capital, LLC | 92,223 | $619.0K | 0.19% | +4,643+5.3% | Added |
| Citadel Advisors LLC | 243,789 | $1.64M | 0.00% | +21,392+9.6% | Added |
| Alyeska Investment Group, L.P. | 274,719 | $1.84M | 0.02% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 300,000 | $2.01M | 0.15% | −252,903−45.7% | Reduced |
| FMR LLC | 353,884 | $2.38M | 0.00% | +353,884 | New |
| Vanguard Group Inc | 532,568 | $3.57M | 0.00% | 00.0% | Unchanged |
| VR Adviser, LLC | 538,999 | $3.62M | 0.59% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 911,736 | $6.12M | 1.45% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 1,262,193 | $8.47M | 0.18% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 1,281,197 | $8.60M | 0.18% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −34,361−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −12,836−100.0% | Sold out |
| Old Well Partners, LLC | 0 | $0 | 0.00% | −12,116−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,259−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,247−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −64−100.0% | Sold out |